UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Hepatitis C Virus Cure and Obesity: Watch the Weight

Journal of general internal medicine : JGIM, 2020-10, Vol.35 (10), p.2836-2837

2020

Volltextzugriff (PDF)

Pharmacologic Therapies in Gastrointestinal Diseases

The Medical clinics of North America, 2016-07, Vol.100 (4), p.827-850

2016

Volltextzugriff (PDF)

Toward the Effective Co-management of Patients with Cirrhosis by Primary Care Providers and Specialists

Digestive diseases and sciences, 2015-09, Vol.60 (9), p.2576-2578

Fox, Rena K.

2015

Volltextzugriff (PDF)

Underrecognition and Suboptimal Quality of Care for Nonalcoholic Fatty Liver Disease Cirrhosis in Primary Care Patients with Diabetes Mellitus

The American journal of medicine, 2024-02, Vol.137 (2), p.172-177.e2

2024

Volltextzugriff (PDF)

Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database

Clinical gastroenterology and hepatology, 2015-12, Vol.13 (13), p.2333-2341.e6

2015

Volltextzugriff (PDF)

When to Consider Liver Transplant During the Management of Chronic Liver Disease

The Medical clinics of North America, 2014, Vol.98 (1), p.153-168

Fox, Rena K., MD, FACP

2014

Volltextzugriff (PDF)

Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs

PloS one, 2019-06, Vol.14 (6), p.e0217471

2019

Volltextzugriff (PDF)

Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study

Journal of hepatology, 2007-10, Vol.47 (4), p.527-537

2007

Volltextzugriff (PDF)

Prospective study of a case-finding algorithm to detect NAFLD with advanced fibrosis in primary care patients

Hepatology communications, 2023-02, Vol.7 (2), p.e0024-e0024

2023

Volltextzugriff (PDF)

Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance

Radiology. Imaging cancer, 2024-01, Vol.6 (1), p.e230118-e230118

2024

Volltextzugriff (PDF)

Going Viral: Why Eliminating the Burden of Hepatitis C Requires Enhanced Cooperation Between Specialists and Primary Care Providers

Digestive diseases and sciences, 2016-12, Vol.61 (12), p.3381-3383

Fox, Rena

2016

Volltextzugriff (PDF)

Hepatitis B—More Treatments, More Testing, Not Enough Data

Journal of general internal medicine : JGIM, 2011-03, Vol.26 (3), p.232-233

Fox, Rena K.

2011

Volltextzugriff (PDF)

Hepatitis C Virus Infection among Prisoners in the California State Correctional System

Clinical infectious diseases, 2005-07, Vol.41 (2), p.177-186

2005

Volltextzugriff (PDF)

Falsely Decreased HbA1c in a Type 2 Diabetic Patient Treated with Dapsone

Endocrine practice, 2014-11, Vol.20 (11), p.e229-232

2014

Volltextzugriff (PDF)

Mo1059 Interim Analysis of HCC Screening and Survival in 1131 Veterans Diagnosed With HCC From 2008-2010

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-998-S-998

2014

Volltextzugriff (PDF)

Mo1036 Development and Validation of a Virtual Child-Turcotte-Pugh Score to Assess Liver Disease Severity in an Administrative Healthcare Database

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-992-S-992

2014

Volltextzugriff (PDF)

Sa1612 PREDICTORS OF THE RECEIPT OF HEPATITIS C VIRUS (HCV) TREATMENT AMONG CURRENT PATIENTS IN A LARGE URBAN HEALTHCARE SYSTEM

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1597-S-1597

2024

Volltextzugriff (PDF)

586 A CASE-FINDING ALGORITHM APPLIED IN THE PRIMARY CARE SETTING TO IDENTIFY UNRECOGNIZED NAFLD WITH HIGH RISK OF ADVANCED FIBROSIS AMONG PATIENTS WITH DIABETES

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-789-S-789

2021

Volltextzugriff (PDF)

Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality

Gastroenterology (New York, N.Y. 1943), 2017-06, Vol.152 (8), p.1954-1964

2017

Volltextzugriff (PDF)

Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.1693-1706.e12

2019

Volltextzugriff (PDF)

Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis

Hepatology (Baltimore, Md.), 2017-03, Vol.65 (3), p.864-874

2017

Volltextzugriff (PDF)

Effects of Metformin Exposure on Survival in a Large National Cohort of Patients With Diabetes and Cirrhosis

Clinical gastroenterology and hepatology, 2021-10, Vol.19 (10), p.2148-2160.e14

2021

Volltextzugriff (PDF)

Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States

Clinical gastroenterology and hepatology, 2018-01, Vol.16 (1), p.106-114.e5

2018

Volltextzugriff (PDF)

Sorafenib for hepatocellular carcinoma managed by non-oncologists: Impact on drug exposure and survival

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.404-404

2017

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJama Internal Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(61)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hepatitis C Virus Cure and Obesity: Watch the Weight

Pharmacologic Therapies in Gastrointestinal Diseases

Toward the Effective Co-management of Patients with Cirrhosis by Primary Care Providers and Specialists

Underrecognition and Suboptimal Quality of Care for Nonalcoholic Fatty Liver Disease Cirrhosis in Primary Care Patients with Diabetes Mellitus

Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database

When to Consider Liver Transplant During the Management of Chronic Liver Disease

Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs

Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study

Prospective study of a case-finding algorithm to detect NAFLD with advanced fibrosis in primary care patients

Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance

Going Viral: Why Eliminating the Burden of Hepatitis C Requires Enhanced Cooperation Between Specialists and Primary Care Providers

Hepatitis B—More Treatments, More Testing, Not Enough Data

Hepatitis C Virus Infection among Prisoners in the California State Correctional System

Falsely Decreased HbA1c in a Type 2 Diabetic Patient Treated with Dapsone

Mo1059 Interim Analysis of HCC Screening and Survival in 1131 Veterans Diagnosed With HCC From 2008-2010

Mo1036 Development and Validation of a Virtual Child-Turcotte-Pugh Score to Assess Liver Disease Severity in an Administrative Healthcare Database

Sa1612 PREDICTORS OF THE RECEIPT OF HEPATITIS C VIRUS (HCV) TREATMENT AMONG CURRENT PATIENTS IN A LARGE URBAN HEALTHCARE SYSTEM

586 A CASE-FINDING ALGORITHM APPLIED IN THE PRIMARY CARE SETTING TO IDENTIFY UNRECOGNIZED NAFLD WITH HIGH RISK OF ADVANCED FIBROSIS AMONG PATIENTS WITH DIABETES

Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality

Cancer health disparities in racial/ethnic minorities in the United States

Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis

Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis

Effects of Metformin Exposure on Survival in a Large National Cohort of Patients With Diabetes and Cirrhosis

Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States

Sorafenib for hepatocellular carcinoma managed by non-oncologists: Impact on drug exposure and survival

Aktive Filter

Suchergebnisse filtern